Abstract:Background: Perineural invasion (PNI) is an important mechanism associated with metastasis in malignancies, including intrahepatic cholangiocarcinoma (ICC), and is correlated with poor prognosis. However, the molecular features and their relationship with the prognosis of ICC patients with PNI remain unclear.Methods: Prognostic implications of PNI were investigated in MSK cohort and was validated in our independent cohort of patients with ICC using the Kaplan–Meier method. PNI-related genomic profiles were analyzed in the MSK cohort, and the PNI-related transcriptomic atlas was examined in the ZS-ICC cohort from our team. GO, KEGG, and ssGSEA analysis were performed. Immunohistochemistry was used to investigate the relationship between PNI and markers of neurons, hydrolases, and immune cells. The efficacy of adjuvant therapy in ICC patients with PNI was also assessed.Findings: A total of 30.6% and 20.7% patients with ICC had PNI in the discovery and validation cohorts respectively. Patients with PNI in both cohorts presented with shortened overall survival (OS) and relapse-free survival (RFS). The PNI showed positive expression of tyrosine hydroxylase (TH), a marker of sympathetic nerves. Patients with PNI showed a high frequency of KRAS mutations, decreased NK cell infiltration, increased neutrophil infiltration, and elevated expression of PD-L1, CD80, and CD86. Patients with PNI benefited from an extended OS after adjuvant therapy with TEGIO, GEMOX, or capecitabine.Interpretation: Our study deciphered the molecular features of a high frequency of KRAS mutation, positive TH expression, increased neutrophil infiltration, and decreased NK cell infiltration in ICC patients with PNI. Patients with PNI showed a poor prognosis after surgery but a good response to adjuvant chemotherapy.Funding Information: This study was supported by the Clinical Research Plan of SHDC (SHDC 2020CR1003A), the Key Disease Joint Research Program of Xuhui District (XHLHGG202103), the National Key Research and Development Program of China (2019YFC1316000), the National Natural Science Foundation of China (81972232), the Clinical Medicine Research Pilot Project of Shanghai Medical School of Fudan University, the Shanghai Municipal Natural Science Foundation (20JC1419103), Beijing Mutual Care Public Welfare Foundation (GDXZ-08-05) and Sanming Project of Medicine in Shenzhen (No. SZSM202003009).Declaration of Interests: There is no competing interest between all authors.Ethics Approval Statement: The study was approved by the Institutional Review Board of Zhongshan Hospital (Y2017-130), and all related procedures conformed to the Declaration of Helsinki.

Distinct Clinical and Prognostic Implication of IDH1/2 Mutation and Other Most Frequent Mutations in Large Duct and Small Duct Subtypes of Intrahepatic Cholangiocarcinoma

Prognostic Significance of IDH1 and IDH2 Mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Integrated Bioinformatics Analysis and Clinical Validation Reveals That High Expression of Mucin 1 in Intrahepatic Cholangiocarcinoma Predicts Recurrence after Curative Resection.

[Relationship between clinical characteristics and myelodysplastic syndrome patients with isocitrate dehydrogenase gene mutations].

Prognostic Values Of Prevalent Gene Mutations In Intrahepatic Cholangiocarcinoma

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma

Spectrum of Findings Seen in Patients With IDH1/2-Mutant Cholangiocarcinoma

IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma

Somatic Mutation Profiling of Intrahepatic Cholangiocarcinoma: Comparison between Primary and Metastasis Tumor Tissues

IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC.

P89.07 A Large-Scale Survey of IDH1/2 Mutation in Chinese Patients with NSCLC

Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers

Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors

The Characterization of IDH1 Mutations in Chinese Biliary Tract Cancers.

Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets

High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma

PD-1/PD-L1 Expression Profiles Within Intrahepatic Cholangiocarcinoma Predict Clinical Outcome

The Clinical Implications and Molecular Features of Intrahepatic Cholangiocarcinoma with Perineural Invasion.

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma